PHARMACY

Face-to-face counseling fills voids that mail order cannot

BY Antoinette Alexander

WHAT IT MEANS AND WHY IT’S IMPORTANT — The news that Walgreens outlined how face-to-face pharmacy and Take Care Clinic programs have been shown to drive better health outcomes further illustrates the fact that human interaction simply does things that mail order cannot.

(THE NEWS: Walgreens: Face-to-face consults with pharmacists, retail clinicians reduce health spend. For the full story, click here.)

As the article states, Walgreens’ research has shown that face-to-face counseling with diabetes patients reduces levels for A1C, blood pressure and LDL; it results in a rise in immunization rates; and helps educate at-risk patients on the importance of receiving a pneumococcal vaccination.

The fact is that having that human interaction in the pharmacy or a retail-based health clinic simply provides a level of quality health care that mail order cannot provide. For example, if a patient comes into a Take Care Clinic during flu season, that’s the opportune time for a nurse practitioner to review the patient’s history, and, if they meet the criteria, also offer the patient a pneumonia vaccine.

Or take a look at the hepatitis B vaccine. There’s been an increase in recommendations for diabetics to receive the hepatitis B vaccine, so diabetics who visit clinics for other services also may be able to receive that additional protection.

These obviously are just two small examples, but the message is loud and clear — the power of pharmacist- and nurse practitioner-led face-to-face programs is significant.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

BI named sponsor of APhA Bowl of Hygeia Award program

BY Alaric DeArment

RIDGEFIELD, Conn. — One of pharmacy’s top awards is getting some support from a German drug maker. Boehringer Ingelheim announced that it became a premier supporter of the American Pharmacists Association’s Bowl of Hygeia Award.

"Just as the Bowl of Hygeia encourages pharmacists to take active roles in their communities, Boehringer Ingelheim has a strong commitment to making more health in its communities," BI executive director for trade sales and operations Bob Belknap said. "Becoming the premier supporter in 2012, and continuing the proud tradition of this program, is something we felt strongly about."

The award, established in 1958, is presented each year by participating state pharmacist associations. In addition to service through their local, state and national pharmacy associations, award recipients devote their time, talent and resources to a wide variety of causes and community service. In all, approximately 3,000 pharmacists have been recognized with the Bowl of Hygeia award in the history of the award.

 


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

NACDS applauds passage of Counterfeit Drug Penalty Enhancement Act

BY Antoinette Alexander

ALEXANDRIA, Va. — The National Association of Chain Drug Stores on Friday applauded the Senate for passage of the Counterfeit Drug Penalty Enhancement Act (S. 1886), which NACDS said would protect the health and safety of consumers by increasing penalties on criminals that engage in the harmful practice of trafficking in counterfeit medications.

The bill is sponsored by Sens. Patrick Leahy, D-Vt., Charles Grassley, R-Iowa, and Michael Bennet, D-Colo.



“We applaud the Senate for their passage of this important legislation, and thank Sens. Leahy, Grassley and Bennet for their leadership in advocating stricter sentences for criminals who put consumers in harm’s way by trafficking counterfeit medications,” NACDS president and CEO Steve Anderson said. “We urge the House to move swiftly in passing this legislation that puts consumer health safety ahead of criminal activities.”  



Endorsed by NACDS, S. 1886 would impose harsher penalties on criminals who produce, buy, sell or purchase counterfeit medications. Under current federal law, there is no distinction between counterfeit medications and other counterfeit products.

 NACDS also has supported efforts to protect consumers from counterfeit and diverted drugs. 

NACDS supports legislation introduced by Sen. Charles E. Schumer, D-N.Y., called the SAFE Doses Act (S.1002). This legislation would provide law enforcement with critical tools to break up sophisticated crime rings that harm consumers by attempting to illegally resell stolen medical products.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES